Lymphoma occurring during pregnancy: Antenatal therapy, complications, and maternal survival in a multicenter analysis

Journal of Clinical Oncology

Volumn 31, Issue 32, 2013, Pages 4132-4139

  Evens, Andrew M ^a,o   Advani, Ranjana ^c   Press, Oliver W ^d   Lossos, Izidore S ^e   Vose, Julie M ^f   Hernandez Ilizaliturri, Francisco J ^g   Robinson, Barrett K ⁱ   Otis, Stavroula ^c   Dagan, Liat Nadav ^e   Abdallah, Ramsey ^h   Kroll Desrosiers, Aimee ^b   Yarber, Jessica L ^j   Sandoval, Jose ^e   Foyil, Kelley ^p   Parker, Linda M ^d   Gordon, Leo I ^j   Blum, Kristie A ^k   Flowers, Christopher R ^l   Leonard, John P ^h   Habermann, Thomas M ^m   Bartlett, Nancy L ⁿ   more..

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^d Fred Hutchinson Cancer Research Center   (United States)

^e UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^g ROSWELL PARK CANCER INSTITUTE   (United States)

^h WEILL CORNELL MEDICAL COLLEGE   (United States)

ⁱ INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j NORTHWESTERN UNIVERSITY   (United States)

^k OHIO STATE UNIVERSITY   (United States)

^l EMORY UNIVERSITY   (United States)

^m MAYO CLINIC   (United States)

ⁿ WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^o TUFTS MEDICAL CENTER   (United States)

^p NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYCLOPHOSPHAMIDE PLUS DOXORUBICIN PLUS PREDNISOLONE PLUS RITUXIMAB PLUS VINCRISTINE; CYTARABINE; DACARBAZINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; LACTATE DEHYDROGENASE; METHOTREXATE; METHYLPREDNISOLONE; PREDNISONE; VINBLASTINE; VINCRISTINE; ANTINEOPLASTIC AGENT;

ADULT; ADVANCED CANCER; ARTICLE; BURKITT LYMPHOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER SURVIVAL; CESAREAN SECTION; DIFFUSE LARGE B CELL LYMPHOMA; DRUG MEGADOSE; FEMALE; FETUS OUTCOME; FOLLICULAR LYMPHOMA; FOLLOW UP; GESTATIONAL AGE; HODGKIN DISEASE; HUMAN; LABOR INDUCTION; LACTATE DEHYDROGENASE BLOOD LEVEL; MAJOR CLINICAL STUDY; MARGINAL ZONE LYMPHOMA; MULTICENTER STUDY; NEWBORN DISEASE; NONHODGKIN LYMPHOMA; OVERALL SURVIVAL; POSTPARTUM HEMORRHAGE; PREECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PREGNANCY TERMINATION; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; T CELL LYMPHOMA; ADOLESCENT; CLINICAL TRIAL; DISEASE FREE SURVIVAL; DRUG EFFECTS; FETUS; KAPLAN MEIER METHOD; LYMPHOMA; MORTALITY; PREGNANCY COMPLICATIONS, NEOPLASTIC; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DISEASE-FREE SURVIVAL; FEMALE; FETUS; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPHOMA; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; PREGNANCY OUTCOME; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84891950541     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2013.49.8220     Document Type: Article

References (25)

1. Brenner B, Avivi I, Lishner M: Haematological cancers in pregnancy. Lancet 379:580-587, 2012
2. Müller AM, Ihorst G, Mertelsmann R, et al: Epidemiology of non-Hodgkin's lymphoma (NHL): Trends, geographic distribution, and etiology. Ann Hematol 84:1-12, 2005
3. Pereg D, Koren G, Lishner M: The treatment of Hodgkin's and non-Hodgkin's lymphoma in pregnancy. Haematologica 92:1230-1237, 2007
4. Van Calsteren K, Heyns L, De Smet F, et al: Cancer during pregnancy: An analysis of 215 patients emphasizing the obstetrical and the neonatal outcomes. J Clin Oncol 28:683-689, 2010
5. Loibl S, Han SN, von Minckwitz G, et al: Treatment of breast cancer during pregnancy: An observational study. Lancet Oncol 13:887-896, 2012
6. Lishner M, Zemlickis D, Degendorfer P, et al: Maternal and foetal outcome following Hodgkin's disease in pregnancy. Br J Cancer 65:114-117, 1992
7. Ward FT, Weiss RB: Lymphoma and pregnancy. Semin Oncol 16:397-409, 1989
8. Kenkre VP, Long WL, Eickhoff JC, et al: Maintenance rituximab following induction chemoimmunotherapy for mantle cell lymphoma: Longterm follow-up of a pilot study from the Wisconsin Oncology Network. Leuk Lymphoma 52:1675-1680, 2011
9. Habermann TM, Witzig TE. Management of non-Hodgkin lymphoma during pregnancy. In: Armitage JO, Mauch PM, Harris NL, et al (eds) Non-Hodgkin Lymphomas (ed 2). Philadelphia, PA, Kluwer Health/Lippincott Williams & Wilkins, 2010, pp. 501-506
10. Wang PH, Chao KC, Lin G, et al: Primary malignant lymphoma of the cervix in pregnancy: A case report. J Reprod Med 44:630-632, 1999
11. Kirkpatrick AW, Bailey DJ, Weizel HA: Bilateral primary breast lymphoma in pregnancy: A case report and literature review. Can J Surg 39:333-335, 1996
12. Magloire LK, Pettker CM, Buhimschi CS, et al: Burkitt's lymphoma of the ovary in pregnancy. Obstet Gynecol 108:743-745, 2006
13. Amant F, Van Calsteren K, Halaska MJ, et al: Long-term cognitive and cardiac outcomes after prenatal exposure to chemotherapy in children aged 18 months or older: An observational study. Lancet Oncol 13:256-264, 2012
14. Abdel-Hady el-S, Hemida RA, Gamal A, et al: Cancer during pregnancy: Perinatal outcome after in utero exposure to chemotherapy. Arch Gynecol Obstet 286:283-286, 2012
15. Gziri MM, Debiève F, De Catte L, et al: Chemotherapy during pregnancy: Effect of anthracyclines on fetal and maternal cardiac function. Acta Obstet Gynecol Scand 91:1465-1468, 2012
16. Van Calsteren K, Berteloot P, Hanssens M, et al: In utero exposure to chemotherapy: Effect on cardiac and neurologic outcome. J Clin Oncol 24:e16-e17, 2006
17. Avilés A, Neri N, Nambo MJ: Long-term evaluation of cardiac function in children who received anthracyclines during pregnancy. Ann Oncol 17:286-288, 2006
18. Germann N, Goffinet F, Goldwasser F: Anthracyclines during pregnancy: Embryo-fetal outcome in 160 patients. Ann Oncol 15:146-150, 2004
19. Avilés A, Neri N, Nambo MJ: Hematological malignancies and pregnancy: Treat or no treat during first trimester. Int J Cancer 131:2678-2683, 2012
20. Cardonick E, Iacobucci A: Use of chemotherapy during human pregnancy. Lancet Oncol 5:283-291, 2004
21. Zemlickis D, Lishner M, Degendorfer P, et al: Fetal outcome after in utero exposure to cancer chemotherapy. Arch Intern Med 152:573-576, 1992
22. Avilés A, Neri N: Hematological malignancies and pregnancy: A final report of 84 children who received chemotherapy in utero. Clin Lymphoma 2:173-177, 2001
23. Bridges RS, Byrnes EM: Reproductive experience reduces circulating 17beta-estradiol and prolactin levels during proestrus and alters estrogen sensitivity in female rats. Endocrinology 147:2575-2582, 2006
24. Lord SJ, Bernstein L, Johnson KA, et al: Breast cancer risk and hormone receptor status in older women by parity, age of first birth, and breastfeeding: A case-control study. Cancer Epidemiol Biomarkers Prev 17:1723-1730, 2008
25. Woo SY, Fuller LM, Cundiff JH, et al: Radiotherapy during pregnancy for clinical stages IA-IIA Hodgkin's disease. Int J Radiat Oncol Biol Phys 23:407-412, 1992